336: Molecular pathogenesis and therapy of urothelial cell carcinoma
This license covers the generation of mouse models of bladder cancer and their use in testing novel therapeutic agents. The goal of the work is to improve understanding of the genetic events that contribute to bladder cancer and to develop new treatments.
Date: Tue Aug 29 14:18:16 BST 2006
